iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/30622099
Urinary Biomarkers of Carcinogenic Exposure among Cigarette, Waterpipe, and Smokeless Tobacco Users and Never Users of Tobacco in the Golestan Cohort Study - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2019 Feb;28(2):337-347.
doi: 10.1158/1055-9965.EPI-18-0743. Epub 2019 Jan 8.

Urinary Biomarkers of Carcinogenic Exposure among Cigarette, Waterpipe, and Smokeless Tobacco Users and Never Users of Tobacco in the Golestan Cohort Study

Arash Etemadi  1   2 , Hossein Poustchi  2   3 , Cindy M Chang  4 , Benjamin C Blount  5 , Antonia M Calafat  5 , Lanqing Wang  5 , Victor R De Jesus  5 , Akram Pourshams  2 , Ramin Shakeri  2 , Meredith S Shiels  6 , Maki Inoue-Choi  6 , Bridget K Ambrose  4 , Carol H Christensen  4 , Baoguang Wang  4 , Gwen Murphy  6 , Xiaoyun Ye  5 , Deepak Bhandari  5 , Jun Feng  5 , Baoyun Xia  5 , Connie S Sosnoff  5 , Farin Kamangar  7 , Paul Brennan  8 , Paolo Boffetta  9 , Sanford M Dawsey  6 , Christian C Abnet  6 , Reza Malekzadeh  10 , Neal D Freedman  6
Affiliations
Comparative Study

Urinary Biomarkers of Carcinogenic Exposure among Cigarette, Waterpipe, and Smokeless Tobacco Users and Never Users of Tobacco in the Golestan Cohort Study

Arash Etemadi et al. Cancer Epidemiol Biomarkers Prev. 2019 Feb.

Abstract

Background: How carcinogen exposure varies across users of different, particularly noncigarette, tobacco products remains poorly understood.

Methods: We randomly selected 165 participants of the Golestan Cohort Study from northeastern Iran: 60 never users of any tobacco, 35 exclusive cigarette, 40 exclusive (78% daily) waterpipe, and 30 exclusive smokeless tobacco (nass) users. We measured concentrations of 39 biomarkers of exposure in 4 chemical classes in baseline urine samples: tobacco alkaloids, tobacco-specific nitrosamines (TSNA), polycyclic aromatic hydrocarbons (PAH), and volatile organic compounds (VOC). We also quantified the same biomarkers in a second urine sample, obtained 5 years later, among continuing cigarette smokers and never tobacco users.

Results: Nass users had the highest concentrations of tobacco alkaloids. All tobacco users had elevated TSNA concentrations, which correlated with nicotine dose. In both cigarette and waterpipe smokers, PAH and VOC biomarkers were higher than never tobacco users and nass users, and highly correlated with nicotine dose. PAH biomarkers of phenanthrene and pyrene and two VOC metabolites (phenylmercapturic acid and phenylglyoxylic acid) were higher in waterpipe smokers than in all other groups. PAH biomarkers among Golestan never tobacco users were comparable to those in U.S. cigarette smokers. All biomarkers had moderate to good correlations over 5 years, particularly in continuing cigarette smokers.

Conclusions: We observed two patterns of exposure biomarkers that differentiated the use of the combustible products (cigarettes and waterpipe) from the smokeless product. Environmental exposure from nontobacco sources appeared to contribute to the presence of high levels of PAH metabolites in the Golestan Cohort.

Impact: Most of these biomarkers would be useful for exposure assessment in a longitudinal study.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Heatmaps of A. nicotine metabolites, other tobacco alkaloids, and nitrosamines, B. biomarkers of PAHs and VOCs among different study groups. Each row shows biomarker concentrations in one individual, and the colors represent the concentrations standardized for each biomarker (z scores shown in the Color Key)
Figure 2.
Figure 2.
Correlation between total nicotine equivalent and PAH biomarkers among never tobacco users, cigarette smokers, waterpipe smokers, and nass users
Figure 3.
Figure 3.
Correlation between total nicotine equivalent and VOCs metabolites among never tobacco users, cigarette smokers, waterpipe smokers, and nass users
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Giovino GA, Mirza SA, Samet JM, Gupta PC, Jarvis MJ, Bhala N, et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 2012;380(9842):668–79 doi 10.1016/S0140-6736(12)61085-X. - DOI - PubMed
    1. Bilano V, Gilmour S, Moffiet T, d’Espaignet ET, Stevens GA, Commar A, et al. Global trends and projections for tobacco use, 1990–2025: an analysis of smoking indicators from the WHO Comprehensive Information Systems for Tobacco Control. Lancet 2015;385(9972):966–76 doi 10.1016/S0140-6736(15)60264-1. - DOI - PubMed
    1. Maziak W Rise of waterpipe smoking. Bmj-Brit Med J 2015;350 doi Artn H1991 10.1136/Bmj.H1991. - DOI - PubMed
    1. Eriksen MP, Mackay J, Schluger NW, Islami F, Drope J. The tobacco atlas. Atlanta, Georgia, 30303, USA: Published by the American Cancer Society,; 2015.
    1. Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smokeless tobacco and cancer. The lancet oncology 2008;9(7):667–75 doi 10.1016/S1470-2045(08)70173-6. - DOI - PubMed

Publication types